Related Experiment Video
Updated: Aug 4, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept
Dorra Guermazi1, Panos Arvanitis1, Dimitrios Farmakiotis2
1Division of Infectious Diseases, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Gerry House 111, Providence, RI, 02903, USA.
No abstract available in PubMed .
More Related Videos
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
07:10Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Related Concept Videos
Antimicrobial Effectiveness
Subviral Agents